EX-2.3 3 d313311dex23.htm DISTRIBUTION AND ASSIGNMENT AGREEMENT Execution Version DISTRIBUTION AND ASSIGNMENT AGREEMENTDistribution and Assignment Agreement • May 5th, 2020 • Delaware
This Distribution and Assignment Agreement (the “Agreement”), dated as of March 12, 2012, is entered into by and between Exelon Corporation, a Pennsylvania corporation (“Exelon”), Constellation Energy Group, Inc., a Maryland corporation and subsidiary of Exelon (“CEG”), and RF HoldCo LLC, a Delaware limited liability company and subsidiary of CEG (“RF HoldCo”).
EXHIBIT 10.23 SECOND AMENDED & RESTATED MANUFACTURING, DISTRIBUTION AND ASSIGNMENT AGREEMENTDistribution and Assignment Agreement • August 20th, 1999 • National Boston Medical Inc • Louisiana
EX-10.32 4 dex1032.htm MEMBERS AGREEMENT CONFIDENTIAL TREATMENT REQUESTED Redacted Portions are indicated by [****] MEMBERS AGREEMENTDistribution and Assignment Agreement • May 5th, 2020 • Delaware
This Members Agreement (this “Agreement”) is made effective as of the 1st day of January, 2008, by and among Genzyme Corporation, a Massachusetts corporation having its principal place of business at 500 Kendall Square, Cambridge, Massachusetts 02142 (“Genzyme”); BioMarin Pharmaceutical Inc., a Delaware corporation having its principal place of business at 105 Digital Drive, Novato, California 94949 (“BioMarin”); BioMarin Genetics, Inc., a Delaware corporation and a wholly-owned subsidiary of BioMarin having its principal place of business at 105 Digital Drive, Novato, California 94949 (“BioMarin Subsidiary”); and BioMarin/Genzyme LLC, a Delaware limited liability company having its principal place of business at 500 Kendall Street, Cambridge, Massachusetts 02142 (the “Company”), of which BioMarin, BioMarin Subsidiary and Genzyme are the only members. Genzyme, BioMarin, BioMarin Subsidiary and the Company are sometimes referred to herein individually as a “Party” and collectively as th
DISTRIBUTION AND ASSIGNMENT AGREEMENTDistribution and Assignment Agreement • November 3rd, 2023 • Can B Corp • Wholesale-drugs, proprietaries & druggists' sundries • New York
THIS DISTRIBUTION AND ASSIGNMENT AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time in accordance with its terms, this “Agreement”), is made and entered into as of October 27, 2023 (the “Effective Date”), by and among, NASCENT PHARMA, LLC, a Nevada limited liability company (“Nascent”), CAN B̅ CORP., a Florida corporation (the “Company”), and WALLEYE OPPORTUNITIES MASTER FUND LTD, a Cayman Islands exempted company with limited liability (“Assignee”, and together with Nascent and the Company, collectively, the “Parties”, and each, individually, a “Party”). Capitalized terms used but not defined herein shall have the meaning given to such terms in the Purchase Agreement (as defined below).
